![logo](/logos/ENZY.ST.webp)
Enzymatica AB (publ)
SSE:ENZY.ST
3.05 (SEK) • At close February 20, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Enzymatica AB (publ) |
Symbool | ENZY.ST |
Munteenheid | SEK |
Prijs | 3.05 |
Beurswaarde | 500,983,850 |
Dividendpercentage | 0% |
52-weken bereik | 2.1 - 4.425 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Ms. Therese Filmersson |
Website | https://www.enzymatica.se |
An error occurred while fetching data.
Over Enzymatica AB (publ)
Enzymatica AB, a life science company, develops and sells medical devices for infection-related diseases. The company's product includes ColdZyme mouth spray, which prevents common cold and reduces the duration of illness. It also provides enzyme formulations. The company sells mouth spray under the ViruProtect brand in Denmark; STADAProtect brand in
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (SEK)
Cijfers zijn in miljoenen (SEK)